Loading companies…
HC
Hope Care
Portugal · Healthtech
Hope Care provides a regulated remote-patient-monitoring platform to health systems and care providers. Its OpMA platform brings patient-reported and connected-device measurements into clinical programmes, where care teams review dashboards and alerts, follow patients remotely and intervene when readings indicate deterioration.
How it works
Hope Care’s OpMA platform consolidates readings from multiple medical devices and other digital systems, then lets provider teams configure clinical protocols and remote-monitoring programmes. Patients share information and stay in contact with their care professionals through a patient interface; clinicians use a dashboard to review patient status, receive alerts and decide when follow-up or intervention is needed.
The company presents the system as interoperable infrastructure for clinical workflows, rather than a patient-facing wellness app. Its site describes deployments with Portuguese health institutions and monitoring programmes including chronic obstructive pulmonary disease (COPD).
Customers and maturity
Healthcare providers use Hope Care to keep patients under follow-up at home and identify signs of clinical deterioration earlier, with the goal of reducing avoidable travel and hospital visits. The company announced a €6 million Series A in September 2026 to expand its European deployments, including planned operations in Germany and Romania; it already operated in Portugal and France and reported projects in Switzerland.
- Product
- OpMA remote monitoring platform
- Headquarters
- Portugal
- Users
- Clinical teams and monitored patients
- Programme type
- Remote patient monitoring
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | €6M | Iberis Capital — LeadBuenavista Equity Partners — ParticipantVieira de Matos – VDM Capital, S.A. — Participant |
Investors
Iberis CapitalLed Series ABuenavista Equity PartnersJoined Series AVieira de Matos – VDM Capital, S.A.Joined Series ACoverage
Sep 8, 2026Hope Care · Series ASimilar companies
GMGeneral MedicineAn online healthcare store where people compare care options and upfront prices, book visits and order medications or lab tests.$120M · Series B
AnaCardioAnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.€62.5M · Series B
Blue Health IntelligenceBlue Health Intelligence combines a one-hour health assessment with doctor-led interpretation and a digital plan for preventive care.€3.4M · €3.4 million growth capital